Summit Securities Group’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Summit Securities Group's OGN Position: Q3 2026 in Review
Summit Securities Group opened a new position in Organon & Co (OGN) in Q3 2026: 30,170 shares worth $413K. The stake represents 0.04% of the portfolio and ranks #211 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in OGN as recently as Q4 2025.
Summit Securities Group first reported a position in OGN in Q1 2022 and has held it in 15 quarters since. The position peaked at $451K in Q2 2024. 607 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- Summit Securities Group held 30,170 shares of Organon & Co worth $413K as of Q3 2026.
- Organon & Co was a new Summit Securities Group position in Q3 2026.
- Organon & Co made up 0.04% of Summit Securities Group's portfolio in Q3 2026, its #211 holding.
- Summit Securities Group first reported a position in Organon & Co in Q1 2022 and has held it in 15 quarters since.
- Summit Securities Group's Organon & Co position peaked at $451K in Q2 2024.
- 607 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on Summit Securities Group's 13F filing for Q3 2026, filed 5 Nov 2026.